UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Telomere Length Is Predictive of Breast Cancer Risk in BRCA2 Mutation Carriers

Cancer epidemiology, biomarkers & prevention, 2017-08, Vol.26 (8), p.1248-1254

2017

Volltextzugriff (PDF)

Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency

Cancer research (Chicago, Ill.), 2017-09, Vol.77 (18), p.4755-4762

2017

Volltextzugriff (PDF)

A DNA methylation-based definition of biologically distinct breast cancer subtypes

Molecular oncology, 2015-03, Vol.9 (3), p.555-568

2015

Volltextzugriff (PDF)

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

Clinical cancer research, 2006-02, Vol.12 (4), p.1157-1167

2006

Volltextzugriff (PDF)

Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers

British journal of cancer, 2016-09, Vol.115 (7), p.776-783

2016

Volltextzugriff (PDF)

Population-Based Study of Changing Breast Cancer Risk in Icelandic BRCA2 Mutation Carriers, 1920–2000

JNCI : Journal of the National Cancer Institute, 2006-01, Vol.98 (2), p.116-122

2006

Volltextzugriff (PDF)

Cytogenetic polyclonality of breast carcinomas: Association with Clinico-Pathological Characteristics and Outcome

Genes chromosomes & cancer, 2011-11, Vol.50 (11), p.930-939

2011

Volltextzugriff (PDF)

Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression

Breast cancer research : BCR, 2011-09, Vol.13 (5), p.R95-R95

2011

Volltextzugriff (PDF)

Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers

JNCI : Journal of the National Cancer Institute, 2007-06, Vol.99 (12), p.929-935

2007

Volltextzugriff (PDF)

Tumour diploidy and survival in breast cancer patients with BRCA2 mutations

Breast cancer research and treatment, 2013-07, Vol.140 (2), p.375-384

2013

Volltextzugriff (PDF)

Breast cancer risk associated with AURKA 91T → A polymorphism in relation to BRCA mutations

Cancer letters, 2007-06, Vol.250 (2), p.206-212

2007

Volltextzugriff (PDF)

BRCA2 heterozygosity delays cytokinesis in primary human fibroblasts

Cellular oncology : the official journal of the International Society for Cellular Oncology, 2009, Vol.31 (3), p.191-201

2009

Volltextzugriff (PDF)

Aurora-A amplification associated with BRCA2 mutation in breast tumours

Cancer letters, 2007-04, Vol.248 (1), p.96-102

2007

Volltextzugriff (PDF)

AURKA and breast cancer in BRCA1/2 mutation carriers

Cancer epidemiology, biomarkers & prevention, 2007-11, Vol.16 (11), p.2517-2517

2007

Volltextzugriff (PDF)

BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability

Cancer research (Chicago, Ill.), 1998-03, Vol.58 (5), p.859-862

1998

Volltextzugriff (PDF)

GSTM1, GSTT1, and GSTP1 Genotypes in Relation to Breast Cancer Risk and Frequency of Mutations in the p53 Gene

Cancer epidemiology, biomarkers & prevention, 2001-11, Vol.10 (11), p.1169-1173

2001

Volltextzugriff (PDF)

Screening for germ line TP53 mutations in breast cancer patients

Cancer research (Chicago, Ill.), 1992-06, Vol.52 (11), p.3234-3236

1992

Volltextzugriff (PDF)

Sensitivity of BRCA2 mutated human cell lines to Aurora kinase inhibition

Investigational new drugs, 2012-04, Vol.30 (2), p.425-434

2012

Volltextzugriff (PDF)

Age at Menarche and Menopause and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study

Cancer epidemiology, biomarkers & prevention, 2007-04, Vol.16 (4), p.740-746

2007

Volltextzugriff (PDF)

p53 abnormalities and genomic instability in primary human breast carcinomas

Cancer research (Chicago, Ill.), 1995-02, Vol.55 (3), p.646-651

1995

Volltextzugriff (PDF)

TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc-binding domains

Genes chromosomes & cancer, 1995-09, Vol.14 (1), p.71-75

1995

Volltextzugriff (PDF)

Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma

The Journal of pathology, 1999-12, Vol.189 (4), p.504-513

1999

Volltextzugriff (PDF)

TP53 Abnormalities and Genetic Instability in Breast Cancer

Acta oncologica, 1995, Vol.34 (5), p.663-667

1995

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

ThemaMutation

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Telomere Length Is Predictive of Breast Cancer Risk in BRCA2 Mutation Carriers

Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency

A DNA methylation-based definition of biologically distinct breast cancer subtypes

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers

Population-Based Study of Changing Breast Cancer Risk in Icelandic BRCA2 Mutation Carriers, 1920–2000

Cytogenetic polyclonality of breast carcinomas: Association with Clinico-Pathological Characteristics and Outcome

Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression

Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers

Tumour diploidy and survival in breast cancer patients with BRCA2 mutations

Breast cancer risk associated with AURKA 91T → A polymorphism in relation to BRCA mutations

BRCA2 heterozygosity delays cytokinesis in primary human fibroblasts

Aurora-A amplification associated with BRCA2 mutation in breast tumours

AURKA and breast cancer in BRCA1/2 mutation carriers

BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability

GSTM1, GSTT1, and GSTP1 Genotypes in Relation to Breast Cancer Risk and Frequency of Mutations in the p53 Gene

Screening for germ line TP53 mutations in breast cancer patients

Sensitivity of BRCA2 mutated human cell lines to Aurora kinase inhibition

Age at Menarche and Menopause and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study

p53 abnormalities and genomic instability in primary human breast carcinomas

TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc-binding domains

Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma

TP53 Abnormalities and Genetic Instability in Breast Cancer

Aktive Filter

Suchergebnisse filtern